Peptides: Beyond the Hype

From metabolic health to cellular repair, Tapp Francke Ingolia, MS, CNS, explores why the biological messengers require clinical oversight to be truly effective.
The right peptide, at the right dose, used for the right duration, has the potential to support healing, enhance performance and improve overall well-being. Photo: Allison Saeng

By Tapp Francke Ingolia, MS, CNS

Peptides are quickly becoming one of the most talked-about innovations in modern health and wellness—and for good reason. These short chains of amino acids act as signaling molecules in the body, telling cells what to do and when to do it. Because of this targeted functionality, peptides are being explored for a wide range of applications. From weight management and increased energy to improved skin health and faster injury recovery, peptides offer a highly personalized approach to optimizing the body. The excitement surrounding them is undeniable—scroll through social media or listen to the latest health podcast, and peptides are everywhere.

In fact, medical experts note that peptides have “quickly moved into the spotlight” for uses ranging from anti-aging to metabolic health, says the Atlanta Journal-Constitution’s website. As Dr. Michelle Fricke, a dermatologist in San Antonio, explains, peptides are “short chains of amino acids—the building blocks of proteins like collagen…crucial for maintaining the skin’s structure, strength and firmness.” It’s this biological precision that makes peptides so compelling: For nearly every concern, there may be a peptide designed to help address it.

However, with this surge in popularity comes a growing concern: access without oversight. When peptides were restricted by the U.S. Food and Drug Administration, demand didn’t disappear; it intensified. In response, a wave of online vendors began selling peptides directly to consumers, often without prescriptions or medical guidance. What has emerged is a peptide free-for-all, where individuals are selecting and dosing compounds on their own without fully understanding what they are taking or how to use it safely.

The associated risks can be significant: cardiovascular strain, cancer, immune system reactions, hormonal imbalances and severe metabolic issues like insulin resistance. As health.com reports, many peptides being sold directly to consumers “aren’t FDA-approved or rigorously studied for safety or effectiveness,” underscoring the uncertainty surrounding their use outside of clinical settings. Even more concerning is the lack of quality control. Without regulatory oversight, there is no guarantee that these products are pure, properly manufactured or even what they claim to be. In some cases, they may be ineffective, while in others, potentially harmful.

To understand how peptides reached this point, it’s important to look at their recent regulatory history. While peptides have been studied for decades, their availability has shifted due to evolving FDA policies. Around 2023, increased scrutiny led to many peptides being removed from compounding pharmacy use after the FDA identified them as substances that may pose “significant safety risks.” This decision limited access for both patients and providers, but it also unintentionally fueled the rise of an unregulated market. Now, the landscape is beginning to shift once again. Regulators are actively reviewing certain peptides for reintroduction into compounding pharmacies under physician supervision. The goal is clear: Restore access while maintaining safety by bringing peptide therapy back into a controlled, medical environment.

As peptides reenter the regulated space, the role of medical professionals becomes more important than ever. When prescribed and monitored appropriately, peptides can be truly transformative. The right peptide, at the right dose, used for the right duration, has the potential to support healing, enhance performance and improve overall well-being. Peptides are powerful biological tools, and their effectiveness depends on precision and personalization. As Dr. Jeffrey Morrison, medical director of both Hamptons BioMed and The Morrison Center, explains, “Peptides represent one of the most exciting frontiers in personalized medicine. I’ve seen both the science and the real-world results—and when used correctly under expert supervision, they can deliver profoundly impactful improvements in health, performance and longevity.” Moving forward, the hope is that patients will shift away from self-experimentation and toward clinically guided care, where safety and results go hand in hand.

Hamptons BioMed offers a physician-led peptide program designed to bring that level of precision and safety to patients. Through comprehensive lab testing and individualized evaluation, the medical team determines the most appropriate peptide protocols for each patient’s unique biology and goals. By combining advanced diagnostics with expert medical oversight, Hamptons BioMed ensures that peptide therapy is not only effective, but safe, personalized and grounded in clinical care. hamptonsbiomed.com